Arktus Therapeutics
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $2.9M
Investors
- 9
About Arktus Therapeutics
Based in Kyoto, Japan, and founded in 2023 by Chief Executive Officer Tomohiro Oiwa, based in Japan, Arktus Therapeutics Inc. operates as a medicine research and development company providing regenerative therapies to create new knee cartilages from stem cells. In September 2025,? Arktus Therapeutics Inc. Arktus Therapeutics Inc. specializes in knee cartilage regeneration medicine using a unique combination of iPS cells and chondrocyte 3D printing technology. This groundbreaking approach addresses the increasing prevalence of knee pain and osteoarthritis by offering a treatment option that surpasses the limitations of conventional methods. By harnessing the patient's own cells, Arktus Therapeutics Inc. enables the restoration of natural movement and function of the knee joint, leading to more effective and personalized recovery outcomes. Their core technologies, including the induction of mesenchymal stem cells from iPS cells and bio-3D printing of chondrocytes, represent significant advancements in the field of regenerative medicine, promising a brighter future for individuals seeking relief from knee-related ailments.
Who invested in Arktus Therapeutics
9 investors across 2 rounds
See all investors in Arktus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arktus Therapeutics
Who invested in Arktus Therapeutics?
Arktus Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arktus Therapeutics raised?
Arktus Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Arktus Therapeutics last raise money?
Arktus Therapeutics's most recent round on record is a Series A, in Sep 2025.
What does Arktus Therapeutics do?
Based in Kyoto, Japan, and founded in 2023 by Chief Executive Officer Tomohiro Oiwa, based in Japan, Arktus Therapeutics Inc.
Where is Arktus Therapeutics headquartered?
Arktus Therapeutics is headquartered in Kyoto-shi, Japan.
Which VCs invest in companies like Arktus Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Arktus Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Arktus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.